000 | 02133 a2200613 4500 | ||
---|---|---|---|
005 | 20250514002706.0 | ||
264 | 0 | _c20010927 | |
008 | 200109s 0 0 eng d | ||
022 | _a1522-8002 | ||
024 | 7 |
_a10.1038/sj.neo.7900128 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOzawa, S | |
245 | 0 | 0 |
_aSuppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _c |
||
300 |
_a154-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xbiosynthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIn Situ Hybridization |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 |
_aInterferon Type I _xtherapeutic use |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLiver Neoplasms _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 8 _xbiosynthesis |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeovascularization, Pathologic |
650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xbiosynthesis |
650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xbiosynthesis |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aSpleen _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aShinohara, H | |
700 | 1 | _aKanayama , H O | |
700 | 1 | _aBruns, C J | |
700 | 1 | _aBucana, C D | |
700 | 1 | _aEllis, L M | |
700 | 1 | _aDavis, D W | |
700 | 1 | _aFidler, I J | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 3 _gno. 2 _gp. 154-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.neo.7900128 _zAvailable from publisher's website |
999 |
_c11350428 _d11350428 |